Back

Beta-blocker therapy after myocardial infarction: an umbrella review

29 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Secondary prevention (1) Secondary Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mrs Pilar Ignacia Cataldo Miranda

Monash University, Melbourne (Australia)

7 More presentations in this session

Presentation thumbnail
Improving vaccine uptake after myocardial infarction: results of an opportunistic counselling strategy in cardiac rehabilitation
Doctor V. Marcos Garces (Valencia, ES)
Abstract Slides
Presentation thumbnail
Residual risk in coronary artery disease: identification of cardio–reno–metabolic and psychosocial phenotypes in a Latinamerican cohort of the INTERASPIRE registry
Doctor J. Perea (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Closing the secondary prevention gap in acute coronary syndrome through system-level metabolic risk standardisation
Doctor A. Roy (Ilford, GB)
Abstract Slides
Presentation thumbnail
P2y12 inhibitors versus aspirin monotherapy for secondary prevention in patients with established atherosclerotic cardiovascular disease: a systematic review and meta-analysis
Doctor N. Ktenopoulos (Athens, GR)
Abstract Slides
Presentation thumbnail
Achievement of secondary prevention targets after STEMI: results from the IMPACS Study
Doctor R. Molnar (Bratislava, SK)
Abstract Slides

Access the full session

Session thumbnail
Secondary prevention (1)

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
The need and duration of BB therapy in post MI patients with preserved left ventricular ejection fraction: a meta-analysis
27 August 2021
thumbnail
Congress Session
Contemporary beta‑blocker pharmacotherapy
31 August 2026
thumbnail
Congress Presentation
Digoxin vs. beta-blocker therapy in atrial fibrillation: analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry
27 August 2021
thumbnail
Congress Presentation
Efficacy and safety of bisoprolol compared to other selective beta-1 blockers in the treatment of hypertension: a systematic review and meta-analysis of randomized parallel clinical trials
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources